Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions

Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions

Show other versions (1)

Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide and often diagnosed at advanced stages with poor prognosis. Combination of radiotherapy and immunotherapy seems to be a promising approach for treating ESCC. This comprehensive review article summarizes the current state of c...

Full description

Bibliographic Details
Main Authors: Mengjie Jiang, Yujie Hu, Gang Lin, Chao Chen, Huafeng Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
esophageal squamous cell carcinoma (ESCC)
radiotherapy
immune checkpoint inhibitor (ICI)
combination efficacy
adverse event (AE)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1177085/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1177085/full

Similar Items